海口腺彩超可以检查什么(克州检中心电话) (今日更新中)

The former police officer who knelt on the neck of George Floyd prior to Floyd's death in May has been released on bail, according to WCCO-TV and The Washington Post.Bail in his case had been set at .25 million, or million with conditions, according to WCCO. NBC News reports that Chauvin's release was conditional.Chauvin has been charged with second-degree murder, third-degree murder and manslaughter in connection with Floyd's death.Three other former police officers — J. Alexander Kueng, Thomas Lane and Tou Thao — face charges of aiding and abetting murder and manslaughter.Floyd's death sparked nationwide protests against systemic racism and police brutality across the country throughout the summer.Ben Crump, a civil rights attorney who has been working with the Floyd statement, decried Chauvin's release. ”Derek Chauvin’s release on bond is a painful reminder to George Floyd’s family that we are still far from achieving justice for George," Crump said in a statement. "The system of due process worked for Chauvin and afforded him his freedom while he awaits trial. In contrast, George Floyd was denied due process, when his life was ended over a bill. There was no charge, no arrest, no hearing, no bail. Just execution. Although George Floyd was denied justice in life, we will not rest until he is afforded full justice in death. The civil litigation team looks forward to our day in court.” 1426

The Cambridge Analytica scandal has had a number of serious repercussions for Facebook, its users, and the future of privacy around the world.It also temporarily stopped single people from finding true love on Tinder.Shortly after Facebook announced stricter rules for its third-party developers, popular dating app Tinder stopped working. Singles who tried to get some swiping in on their lunch breaks weren't allowed to log in to the app. A pop-up window said "Tinder requires you to provide additional Facebook permissions in order to create or use a Tinder account." Like many apps, Tinder primarily lets people log in with their Facebook credentials."This was part of the changes that we announced today, and we are working with Tinder to address this issue," a Facebook spokesperson told CNN Tech.Upset Tinder users took to Twitter to vent.Facebook is still recovering from revelations that Cambridge Analytica, a data firm with connections to the Trump campaign, accessed the data of millions of its users. Facebook has been rushing to repair its relationship with users, and prevent any future misuses of data by third-parties.On Wednesday, it announced changes to what personal information apps can collect."We will also no longer allow apps to ask for access to personal information such as religious or political views, relationship status and details, custom friends lists, education and work history, fitness activity, book reading activity, music listening activity, news reading, video watch activity, and games activity," Facebook said in its post.It is unclear exactly which part of Facebook's updates caused the issues with Tinder. The app shows you information about potential paramours like age, location and where they went to school. Other dating apps that use Facebook to login, like Bumble, did not experience outages.After Tinder was fixed, many users said their matches were all missing. After a few hours, those matches appeared to have been restored as well.As off Wednesday afternoon, people were able to use the app and -- if only for a moment -- feel a little less alone in the world. 2123

The Food and Drug Administration released updated safety standards Tuesday for makers of COVID-19 vaccines despite efforts by the White House to block them, clearing the way for requirements that are widely expected to prevent the introduction of a vaccine before Election Day.In the new guidelines posted on its website, the FDA said vaccine makers should follow trial participants for at least two months to rule out any major side effects before seeking emergency approval. That standard had been a sticking point between the FDA and White House officials, who said it could unreasonably delay the availability of COVID-19 vaccines.President Donald Trump has repeatedly insisted a vaccine could be authorized before Nov. 3, even though top government scientists working on the effort have said that timeline is very unlikely. On Monday Trump said vaccines are coming “momentarily,” in a video recorded after he returned to the White House.Former FDA officials have warned that public perception that a vaccine was being rushed out for political reasons could derail efforts to vaccinate millions of Americans.A senior administration official confirmed Monday that the White House had blocked FDA’s plans to formally publish the safety guidelines based on the two-month data requirement, arguing there was “no clinical or medical reason” for it.But on Tuesday, the FDA posted the guidance on its website, making clear that regulators plan to impose the safety standards for any vaccine seeking an expedited path to market.FDA Commissioner Stephen Hahn said in a statement that he hoped the guidelines would help “the public understand our science-based decision-making process that assures vaccine quality, safety and efficacy.”The requirements are aimed at companies seeking rapid approval through the FDA’s emergency authorization pathway. That accelerated process, reserved for health emergencies, allows medical products onto the market based on a lower bar than traditional FDA approval. But FDA has made clear only vaccines that are shown to be safe and effective will be authorized for coronavirus.Former FDA acting commissioner Dr. Stephen Ostroff said the requirements seem reasonable given the agency is in largely “uncharted territory” in terms of considering emergency use of a vaccine. The agency has only previously cleared one vaccine through the method — a decades-old shot that was authorized to prevent anthrax poisoning in 2005.“There really is no margin for error here,” Ostroff said. “Even when you’re talking about limited use of a vaccine there has to be some level of assurance that there isn’t a risk here that would far outweigh the benefit.”Dr. Peter Marks, the head of FDA’s vaccine division, said Tuesday that the two-month follow-up requirement was chosen to be “something reasonably aggressive, but not too conservative — right in the middle.” He spoke at a symposium organized by Johns Hopkins University.Initial doses of vaccines for emergency use would likely be reserved for medical workers and people with health conditions that make them particularly vulnerable to coronavirus. Full FDA approval for the general population will require significantly more data and is not expected until mid-2021.The White House attempt to block the guidance followed a string of instances in which the Trump administration has undercut its own medical experts working to combat the pandemic. FDA’s Hahn has been attempting to shore up public confidence in the vaccine review process for weeks, vowing that career scientists, not politicians, will decide if the shots are safe and effective.Pfizer CEO Albert Bourla has stoked excitement by saying that he expects data on whether the company’s candidate works to be ready in late October. But a number of variables would still have to align for the company to submit, and the FDA to review and greenlight, a vaccine application before Nov. 3. Pfizer’s competitors Moderna, AstraZeneca and Johnson & Johnson are working on longer research timelines.Vaccine development typically takes years, but the U.S. government has invested billions in efforts to accelerate the process and help multiple drugmakers prepare multiple candidates. All the doses will be purchased by the federal government for use vaccinating the U.S. population.Beyond exposing the rift between the White House and FDA, the delay in releasing the guidelines may have had limited practical effect.FDA scientists have been discussing the guidelines publicly for weeks and have made clear that the recommendations have already been shared with each of the vaccine developers.Former FDA Commissioner Scott Gottlieb said Tuesday that drugmakers depend on the FDA’s science-based endorsement to vouch for the safety and effectiveness of their products.“I can’t imagine a circumstance where a sponsor would challenge or seek to undermine the FDA’s role here,” Gottlieb said at the COVID-19 symposium. “This is precisely the moment when we need an objective, neutral arbiter.”Last week, Gottlieb and six other former FDA commissioners blasted the Trump administration for “undermining the credibility” of the agency in a op-ed calling for the release of the then-stalled vaccine guidelines.“Scientists should make decisions based on data, unfettered by political pressure or the intrusions of ideology or vested interests,” the officials wrote.___AP Medical Writer Lauran Neergaard contributed to this report.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5644

The Girl Scouts of the USA have appointed their first-ever Black CEO.On Monday, Judith Batty took over as Interim CEO after Sylvia Acevedo, who was with the Girl Scouts for four years, stepped down on Aug. 10. Acevedo's last day with the organization was Saturday."When I was young, the Girl Scouts instilled in me the courage, confidence, and character that have guided me through my life and career. It is an incredible honor to bring those lessons back full circle to help the Girl Scouts navigate this transition," said Judith Batty, interim CEO of GSUSA in the press release. "As families across the country contend with so much uncertainty and upheaval, I am committed to ensuring that the Girl Scouts continues to offer shelter in the storm - a place where all our girls feel welcome can find community, solidarity, leadership opportunities and fun, despite the challenging moment we are all collectively living through."Batty began in the organization as a Brownie with the Nassau County Council in New York. She continued scouting over the years, later serving two terms on the National Board. Per CNN, Batty served for nearly 30 years as both a corporate executive and senior legal counsel for ExxonMobil.While at ExxonMobil, she became the first woman and first Black General Counsel of the affiliate in Japan, CNN reported. 1343

The Department of Veteran's Affairs (VA) is facing a huge undertaking as COVID-19 vaccines roll out to the general public.More than 418,000 healthcare workers and 10 million patients will eventually get the COVID-19 vaccine through the VA.The department received 73,000 doses of Pfizer's COVID-19 vaccine this week, and residents and staff at long term communities run by the department are first in line to be inoculated.There are about 17,500 veterans living in VA long-term care facilities across the country, and several thousand more work in those centers.The vaccine could not have arrived sooner for those staff members and patients."I know a lot of VA medical centers are going through COVID surges right now, alongside with their communities," said Dr. Jane Kim, the Chief Consultant for Preventive Medicine at the VA.Most vaccines are mandatory for military members. For now, the COVID-19 vaccine is still voluntary. That's likely due to the limited supply of the vaccine and because it's only under Emergency Use Authorization right now.Still, veteran doctors want to reassure their patients."I got the vaccine yesterday," Kim said. "I had a sore arm yesterday, but my arm feels good today. I feel fine today. I would recommend this vaccine to my family and also my patients when it's available for them and it's their turn."More than 5,500 veteran patients and 87 VA staff members have died of COVID-19 since the start of the pandemic. That doesn't include state-run veteran's homes.The VA is not responsible for providing COVID-19 vaccines to those state-run veteran's homes. 1596

来源：资阳报